These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14613080)

  • 21. Angiogenesis-related prognosis in patients with oral squamous cell carcinoma-role of the VEGF +936 C/T polymorphism.
    Kämmerer PW; Al-Nawas B; Kalkan S; Liese J; Fruth K; Frerich B; Brieger J
    J Oral Pathol Med; 2015 Jul; 44(6):429-36. PubMed ID: 25213013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
    Shang ZJ; Li JR; Li ZB
    Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression of receptor for advanced glycation end products is associated with angiogenesis in human oral squamous cell carcinoma.
    Sasahira T; Kirita T; Bhawal UK; Ikeda M; Nagasawa A; Yamamoto K; Kuniyasu H
    Virchows Arch; 2007 Mar; 450(3):287-95. PubMed ID: 17235565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of vascular endothelial growth factor-C correlates with the lymphatic microvessel density and the nodal status in oral squamous cell cancer.
    Sedivy R; Beck-Mannagetta J; Haverkampf C; Battistutti W; Hönigschnabl S
    J Oral Pathol Med; 2003 Sep; 32(8):455-60. PubMed ID: 12901726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microvascular density analysis and histological parameters of oral cancer progression.
    Batistella EA; Miguel AFP; Nascimento NL; Horta MCR; Vieira DSC; Rivero ERC
    Oral Dis; 2024 May; 30(4):2110-2121. PubMed ID: 37486622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
    Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RhoC, vascular endothelial growth factor and microvascular density in esophageal squamous cell carcinoma.
    Zhao ZH; Tian Y; Yang JP; Zhou J; Chen KS
    World J Gastroenterol; 2015 Jan; 21(3):905-12. PubMed ID: 25624724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of vascular endothelial growth factor-C and angiogenesis in esophageal squamous cell carcinoma.
    Ding MX; Lin XQ; Fu XY; Zhang N; Li JC
    World J Gastroenterol; 2006 Jul; 12(28):4582-5. PubMed ID: 16874878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma.
    Faustino SE; Oliveira DT; Nonogaki S; Landman G; Carvalho AL; Kowalski LP
    Int J Oral Maxillofac Surg; 2008 Apr; 37(4):372-8. PubMed ID: 18295452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenesis and expression of platelet-derived endothelial cell growth factor in oral squamous cell carcinoma.
    Alcalde RE; Terakado N; Otsuki K; Matsumura T
    Oncology; 1997; 54(4):324-8. PubMed ID: 9216858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The expression difference of VEGF, PDGF/dThdPase and MVD on primary hypopharyngeal carcinoma and metastasis lymph nodes].
    Dong P; Yoshimi M; Tadashi N
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Sep; 16(9):451-3. PubMed ID: 15515527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of survivin and its correlation to angiogenesis in oral squamous cell carcinoma].
    Liu YM; Huang JH; Feng DY; Guo XC
    Ai Zheng; 2005 Nov; 24(11):1354-7. PubMed ID: 16552962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poor prognostic clinicopathologic features correlate with VEGF expression but not with PTEN expression in squamous cell carcinoma of the larynx.
    Sullu Y; Gun S; Atmaca S; Karagoz F; Kandemir B
    Diagn Pathol; 2010 Jun; 5():35. PubMed ID: 20546613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VEGF is up-regulated by hypoxic stimulation and related to tumour angiogenesis and severity of disease in oral squamous cell carcinoma: in vitro and in vivo studies.
    Shang ZJ; Li ZB; Li JR
    Int J Oral Maxillofac Surg; 2006 Jun; 35(6):533-8. PubMed ID: 16388929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma.
    Shintani S; Li C; Ishikawa T; Mihara M; Nakashiro K; Hamakawa H
    Oral Oncol; 2004 Jan; 40(1):13-20. PubMed ID: 14662410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The retinoic acid receptor-beta (RAR-beta) mRNA expression in the oral squamous cell carcinoma associated with betel quid use.
    Kao SY; Tu HF; Chang KW; Chang CS; Yang CC; Lin SC
    J Oral Pathol Med; 2002 Apr; 31(4):220-6. PubMed ID: 12076325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors.
    Seki S; Fujiwara M; Matsuura M; Fujita S; Ikeda H; Asahina I; Ikeda T
    Oral Oncol; 2011 Jul; 47(7):588-93. PubMed ID: 21602095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial cell Bcl-2 and lymph node metastasis in patients with oral squamous cell carcinoma.
    Tarquinio SB; Zhang Z; Neiva KG; Polverini PJ; Nör JE
    J Oral Pathol Med; 2012 Feb; 41(2):124-30. PubMed ID: 21936874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma.
    Moriyama M; Kumagai S; Kawashiri S; Kojima K; Kakihara K; Yamamoto E
    Oral Oncol; 1997 Sep; 33(5):369-74. PubMed ID: 9415339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional difference in intratumoral lymphangiogenesis of oral squamous cell carcinomas evaluated by immunohistochemistry using D2-40 and podoplanin antibody: an analysis in comparison with angiogenesis.
    Ohno F; Nakanishi H; Abe A; Seki Y; Kinoshita A; Hasegawa Y; Tatematsu M; Kurita K
    J Oral Pathol Med; 2007 May; 36(5):281-9. PubMed ID: 17448138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.